Olmesartan-induced enteropathy treated with budesonide.

Sander Kempenaers, Julie Van Bogaert, Marc De Maeyer, P Van Hauthem, M. Ramael, Patrick Schoeters

PubMed · 2019 · 10 citations · 5 references

Concepts

Abstract

Olmesartan, an angiotensin receptor blocker, is a widely spread antihypertensive drug. Seronegative villous atrophy of the small intestine due to olmesartan use was first described in 2012. We present a new case of olmesartan-induced enteropathy and compare it to recent literature. This case might suggest a use of budesonide for treatment.

References

5